Pennant Group Inc (PNTG) FinancialsPNTGPennant Group Inc

The Pennant Group, Inc. (PNTG) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medicare, accounting for 50.9% of total sales, equivalent to $151.65M. Other significant revenue streams include Private and other and Medicaid. Understanding this composition is critical for investors evaluating how PNTG navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, The Pennant Group, Inc. maintains a gross margin of 12.91%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.22%, while the net margin is 3.66%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively PNTG converts its operational activities into shareholder value.

In the context of the broader market, PNTG competes directly with industry leaders such as AGL and NUTX. With a market capitalization of $1.40B, it holds a significant position in the sector. When comparing efficiency, PNTG's gross margin of 12.91% stands against AGL's 12.82% and NUTX's 67.04%. Such benchmarking helps identify whether The Pennant Group, Inc. is trading at a premium or discount relative to its financial performance.

The company has demonstrated consistent revenue growth, with Q2 2026 revenue reported at $298 million and a net income of $9.08 million, reflecting a solid operational performance. The gross margin has improved to 12.91% in Q2 2026, indicating better cost management.